Exodus Point Capital Management, LP Revance Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

$16.4 Billion
Q3 2024

A detailed history of Exodus Point Capital Management, LP transactions in Revance Therapeutics, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 125,000 shares of RVNC stock, worth $321,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares

125,000

Previous 441,584 71.69%

Holding current value

$321,250

Previous $1.14 Million 42.82%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$2.57 - $2.57 $813,620 - $813,620	-316,584 Reduced 71.69%	125,000 $649,000
Q2 2024 Aug 13, 2024	BUY	$2.34 - $4.73 $1.03 Million - $2.09 Million	441,584 New	441,584 $1.14 Million
Q2 2023 Aug 10, 2023	BUY	$24.7 - $37.61 $675,421 - $1.03 Million	27,345 New	27,345 $692,000
Q3 2022 Nov 10, 2022	SELL	$14.33 - $28.47 $1.03 Million - $2.05 Million	-71,966 Closed	0 $0
Q2 2022 Aug 19, 2022	BUY	$11.52 - $20.4 $829,048 - $1.47 Million	71,966 New	71,966 $995,000
Q1 2022 May 13, 2022	SELL	$12.36 - $20.31 $544,297 - $894,391	-44,037 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$12.46 - $27.87 $156,559 - $350,186	12,565 Added 39.92%	44,037 $719,000
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $20,056 - $25,837	-778 Reduced 2.41%	31,472 $877,000
Q2 2021 Aug 16, 2021	SELL	$26.8 - $31.84 $1,849 - $2,196	-69 Reduced 0.21%	32,250 $956,000
Q1 2021 May 17, 2021	BUY	$24.03 - $29.97 $379,962 - $473,885	15,812 Added 95.79%	32,319 $903,000
Q4 2020 Feb 16, 2021	SELL	$23.41 - $28.34 $1.62 Million - $1.96 Million	-69,152 Reduced 80.73%	16,507 $468,000
Q3 2020 Nov 16, 2020	BUY	$23.23 - $34.3 $842,389 - $1.24 Million	36,263 Added 73.41%	85,659 $2.15 Million
Q2 2020 Aug 14, 2020	BUY	$12.6 - $26.55 $622,389 - $1.31 Million	49,396 New	49,396 $1.21 Million
Q1 2020 May 15, 2020	SELL	$12.46 - $27.81 $146,591 - $327,184	-11,765 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $137,179 - $237,064	11,765 New	11,765 $191,000

Others Institutions Holding RVNC

# of Institutions

231

Shares Held

83.2M

Call Options Held

680K

Put Options Held

896K

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Revance Therapeutics, Inc. Transaction History